These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 25311702)

  • 1. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
    Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
    Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
    Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
    Hasegawa M; Ishii J; Kitagawa F; Takahashi K; Hayashi H; Koide S; Tomita M; Takahashi H; Ozaki Y; Yuzawa Y
    Heart Vessels; 2015 Jan; 30(1):81-8. PubMed ID: 24378882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients.
    Lin HY; Hwang DY; Lee SC; Kuo HT; Kuo MC; Chang JM; Tsai JC; Hung CC; Hwang SJ; Chen HC
    Clin Chem Lab Med; 2015 Jan; 53(1):73-83. PubMed ID: 25153411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men.
    Helmersson-Karlqvist J; Larsson A; Carlsson AC; Venge P; Sundström J; Ingelsson E; Lind L; Arnlöv J
    Atherosclerosis; 2013 Apr; 227(2):408-13. PubMed ID: 23375682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C
    Crit Care; 2014 Feb; 18(1):R39. PubMed ID: 24581340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders.
    Jotwani V; Katz R; Ix JH; Gutiérrez OM; Bennett M; Parikh CR; Cummings SR; Sarnak MJ; Shlipak MG
    Am J Kidney Dis; 2018 Aug; 72(2):205-213. PubMed ID: 29602632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
    Shrestha K; Shao Z; Singh D; Dupont M; Tang WH
    Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
    Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).
    Peralta C; Scherzer R; Grunfeld C; Abraham A; Tien P; Devarajan P; Bennett M; Butch A; Anastos K; Cohen M; Nowicki M; Sharma A; Young M; Sarnak M; Parikh C; Shlipak M
    HIV Med; 2014 May; 15(5):291-300. PubMed ID: 24313986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A; Hutayanon P; Piyayotai D
    BMC Nephrol; 2013 Dec; 14():270. PubMed ID: 24305547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.